Cytocell Ltd. recalls TCL1 Breakapart Probe, Fluorescence in situ hybridisation (FISH) is a technique allows the visualisation of DNA sequenc…
- Recall date
- February 4, 2022
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-0814-2022
- FDA classification
- Class III
- Brand / firm
- Cytocell Ltd.
- Sold / distributed
- MN
Why it was recalled
May show unexpected locus specific signals in addition to those at 14q32.
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
TCL1 Breakapart Probe, Fluorescence in situ hybridisation (FISH) is a technique allows the visualisation of DNA sequences upon chromosome Catalog Number: LPH046-A
Get recall alerts
Free email alert whenever Cytocell Ltd. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Cytocell Ltd.